Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T59328 | Target Info | |||
Target Name | Epidermal growth factor receptor (EGFR) | ||||
Synonyms | Receptor tyrosine-protein kinase erbB-1; Proto-oncogene c-ErbB-1; HER1; ERBB1; ERBB | ||||
Target Type | Successful Target | ||||
Gene Name | EGFR | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (20R)-10,15,20-trimethyl-2-[(4-methylpiperazin-1-yl)methyl]-18,19,20,21-tetrahydro-15H,17H-12,8-(metheno)pyrazolo[3',4':2,3][1,5,10,12]oxatriazacycloheptadecino[12,11-a]benzimidazol-7(6H)-one | Ligand Info | |||
Canonical SMILES | CC1CCCOC2=C(C=NN2C)C3=NC(=CC(=C3)C(=O)NC4=NC5=C(N4C1)C=C(C=C5)CN6CCN(CC6)C)C | ||||
InChI | 1S/C30H38N8O2/c1-20-6-5-13-40-29-24(17-31-36(29)4)26-16-23(14-21(2)32-26)28(39)34-30-33-25-8-7-22(15-27(25)38(30)18-20)19-37-11-9-35(3)10-12-37/h7-8,14-17,20H,5-6,9-13,18-19H2,1-4H3,(H,33,34,39)/t20-/m1/s1 | ||||
InChIKey | AIQBYZOTCIQTGW-HXUWFJFHSA-N | ||||
PubChem Compound ID | 139600318 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7KXZ Active conformation of EGFR kinase in complex with BI-4020 | ||||||
Method | X-ray diffraction | Resolution | 2.40 Å | Mutation | No | [1] |
PDB Sequence |
GEAPNQALLR
705 ILKETEFKKI715 KVLGSGAFGT725 VYKGLWIPEG735 EKVKIPVAIK745 ELSPKANKEI 759 LDEAYVMASV769 DNPHVCRLLG779 ICLTSTVQLI789 TQLMPFGCLL799 DYVREHKDNI 809 GSQYLLNWCV819 QIAKGMNYLE829 DRRLVHRDLA839 ARNVLVKTPQ849 HVKITDFGLA 859 KLLGAEEKEY869 HAEGGKVPIK879 WMALESILHR889 IYTHQSDVWS899 YGVTVWELMT 909 FGSKPYDGIP919 ASEISSILEK929 GERLPQPPIC939 TIDVYMIMVK949 CWMIDADSRP 959 KFRELIIEFS969 KMARDPQRYL979 VIQGDERMMD1008 DVVDADEYL
|
|||||
|
LEU718
3.714
GLY719
4.633
PHE723
3.555
VAL726
3.575
ALA743
3.590
LYS745
3.007
GLU762
4.274
MET766
4.867
CYS775
3.286
THR790
2.974
GLN791
3.218
|
|||||
PDB ID: 7KY0 Inactive conformation of EGFR (T790M/V948R) kinase in complex with BI-4020 | ||||||
Method | X-ray diffraction | Resolution | 3.10 Å | Mutation | Yes | [2] |
PDB Sequence |
NQALLRILKE
709 TEFKKIKVLG719 SGAFGTVYKG729 LWIPEGEKVK739 IPVAIKELRE749 ATSPKANKEI 759 LDEAYVMASV769 DNPHVCRLLG779 ICLTSTVQLI789 MQLMPFGCLL799 DYVREHKDNI 809 GSQYLLNWCV819 QIAKGMNYLE829 DRRLVHRDLA839 ARNVLVKTPQ849 HVKITDFGLA 859 KLVPIKWMAL883 ESILHRIYTH893 QSDVWSYGVT903 VWELMTFGSK913 PYDGIPASEI 923 SSILEKGERL933 PQPPICTIDV943 YMIMRKCWMI953 DADSRPKFRE963 LIIEFSKMAR 973 DPQRYLVIQG983 DERMHLPSPT993 DSNFYRALMD1003 EEDM
|
|||||
|
LYS716
3.781
VAL717
4.064
LEU718
3.512
GLY719
4.590
SER720
4.011
GLY721
4.965
VAL726
3.542
ALA743
3.658
LYS745
2.727
CYS775
4.120
MET790
3.389
GLN791
3.269
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural analysis of the macrocyclic inhibitor BI-4020 binding to the active and inactive conformations of EGFR kinase | ||||
REF 2 | Structural analysis of the macrocyclic inhibitor BI-4020 binding to the active and inactive conformations of EGFR kinase |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.